Whole body MRI in paediatric oncology  by Canale, S. et al.
Diagnostic and Interventional Imaging (2014) 95, 541—550
REVIEW / Pediatric imaging
Whole  body  MRI  in  paediatric  oncology
S.  Canale ∗,  L.  Vilcot,  S.  Ammari,  M.  Lemery,
F.  Bidault,  C.  Balleyguier,  C.  Caramella,  C.  Dromain
Service  de  radiologie  diagnostique,  Institut  Gustave-Roussy,  114,  rue  Edouard-Vaillant,  94805
Villejuif,  France
KEYWORDS
Whole  body  MRI;
Oncology;
Paediatric;
Tumour  evaluation
Abstract  Whole  body  MRI  provides  excellent  contrast  resolution  imaging  and  is  an  interest-
ing alternative  to  nuclear  medicine  examinations  in  paediatric  oncology  because  it  does  not
involve exposure  to  radiation.  This  technique,  now  feasible  in  clinical  practice,  helps  to  eval-
uate metastatic  spread  and  response  to  treatment,  which  are  of  great  prognostic  interest.
Numerous studies  have  demonstrated  the  non-inferiority  of  this  technique  when  compared  to
nuclear medicine  examinations.  However,  there  is  still  a  need  to  standardize  indications  in  each
type of  cancer  and  at  every  stage  of  it.  This  article  ﬁrst  discusses  the  technical  principles  of
whole body  MRI,  then  reviews  current  clinical  applications  for  the  modality  in  children,  and
ﬁnally, discusses  future  useful  developments  for  paediatric  oncology.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Whole  body  imaging  is  essential  in  oncology.  It  enables  the  assessment  of  the  initial
metastatic  spread  and  the  response  to  treatment,  which  are  of  great  prognostic  value  in
the  care  of  patients.  Whole  body  imaging  is  currently  used  in  routine  clinical  practice  more
than  any  nuclear  medicine  procedure:  scintigraphy,  positron  emission  tomography  with
ﬂuorodesoxyglucose  (PET-FDG)  and  PET-computed  tomography  (PET-CT).  These  procedures
involve  exposure  to  ionizing  radiation,  suspected  of  increasing  the  long-term  risk  of  cancer
[1].  Until  recently,  magnetic  resonance  imaging  (MRI)  was  restricted  to  localized  zones.
With  the  technological  progress  in  MRI,  it  is  now  possible  to  cover  the  whole  human  body  in
a  reasonable  lapse  of  time.  The  ﬁrst  studies  concerning  the  feasibility  of  the  technique  on
adult  subjects  were  published  about  ﬁfteen  years  ago  [2]. The  feasibility  and  assessment
of  this  procedure  in  paediatric  oncology  have  been  reported  in  the  literature  over  the  last
ten  years  [3,4].  Along  with  a  continued  increase  in  the  rate  of  survival  of  the  child  with
malignant  tumours  (80%  of  the  patients  reach  adulthood),  the  long-term  consequences
of  ionizing  radiation  are  increasing  and  need  to  be  taken  into  account  [5].  Therefore,
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ue  to  its  excellent  contrast  resolution  imaging  and  the  fact
hat  it  does  not  involve  exposure  to  radiation,  WB-MRI  is  an
specially  attractive  alternative  in  paediatric  oncology.
We  will  ﬁrst  discuss  the  technical  principles  of  WB-MRI,
hen,  in  light  of  an  exhaustive  review  of  the  literature,  we
ill  describe  the  current  clinical  applications  for  the  pro-
edure,  and  ﬁnally  discuss  future  useful  developments  in
aediatric  oncology.
echnical aspects of whole body MRI
WB-MRI)
rinciples
B-MRI  involves  the  acquisition  of  whole  body  images,  from
he  top  of  the  head  to  the  tip  of  the  toes,  in  one  or  sev-
ral  planes  using  one  or  several  image  weightings.  Initial
ttempts  at  WB-MRI  required  the  successive  imaging  of  each
one  of  the  body  while  repositioning  the  patient  several
imes  in  order  to  cover  the  entire  body  [6].  This  procedure
as  very  long.  A  certain  number  of  innovations  now  allow
B-MR  imaging  to  be  performed  in  a  more  reasonable  time
rame.  The  ﬁrst  of  these  innovations  was  the  use  of  a  rolling
able  platform,  allowing  the  patient  to  be  moved  in  stages
hrough  the  magnetic  bore  [7,8].  The  second  innovation  was
he  availability  on  the  market  of  multiple-phased  array  coils
hat  improve  the  resolution  of  the  image  [9,10]. The  use
f  this  type  of  coil  has  the  advantage  that  local  imaging  of
he  tumour  with  a  good  resolution  can  be  combined  with
n  assessment  of  the  whole  body  as  recommended  by  cer-
ain  authors  [11].  The  idea  of  a  double  examination,  both
ocal  and  metastatic,  is  of  interest  in  paediatrics  since  it
an  be  carried  out  in  the  same  session  of  sedation  or  gen-
ral  anaesthesia  [12],  although  the  time  of  examination
s  considerably  increased.  Finally,  the  time  of  examination
as  been  shortened  by  the  new  parallel  imaging  techniques
13].
The  current  WB-MRI  procedure  consists  of  acquiring
eries  of  images  in  slices  by  successive  stations.  The  num-
er  is  a  function  of  the  ﬁeld  of  view  and  the  size  of  the
atient.  These  series  are  then  merged  cranio-caudally  using
ost-processing  software  (Fig.  1).  It  is  therefore  possible  to,
n  turn,  analyze  each  station  for  the  diagnosis  and  obtain
 global  coronal  view  as  in  nuclear  medicine  examinations.
 complementary  sagittal  plane  is  often  recommended  for
he  analysis  of  the  spine  due  to  the  physiological  curves.  The
ecommended  thickness  of  the  slice  ranges  from  4  to  8  mm  in
ontiguous  sections.  MR  imaging  of  the  thorax  and  abdomen
resent  speciﬁc  problems  due  to  the  movements  caused  by
he  respiration  and  intestinal  peristaltism.  Certain  authors
ecommend  using  respiratory  gating  in  the  acquisition  on  the
runk  in  order  to  reduce  movement  artifacts,  and  the  prior
njection  of  intestinal  anti-peristaltics.
equences
TIR
ue  to  the  great  variability  in  the  technical  parameters
etween  the  different  manufacturers  of  MRI  and  the  still
ecent  nature  of  WB-MRI,  a  consensus  still  has  not  been
l
b
s
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eached  about  which  combination  of  sequences  provides  the
ighest  diagnostic  accuracy  while  maintaining  reasonable
ime  efﬁciency.  Most  initial  studies  in  paediatric  oncology
sed  coronal  slices  in  Short  Tau  Inversion  Recuperation  (STIR)
equences  [3,4,13].
STIR  sequences  are  highly  sensitive  to  bone  and  soft  tissue
nomalies  due  to  a  short  inversion  time  (TI)  that  eliminates
he  fat  signal,  and  double  T1-  and  T2-weighting  [14].  Most
athological  tissue  is  rich  in  protons,  thereby,  lengthening
1  and  reducing  T2.  This  creates  an  intense  hypersignal  with
TIR  sequences.  The  signal  of  other  substances  with  a  short
1  relaxation  time  is  also  reduced  (blood,  liquid  protein,
elanin  and  gadolinium)  [3],  accounting  for  the  fact  that
 STIR  sequence  is  never  carried  out  after  the  injection  of
adolinium.  The  suppression  of  the  fat  signal  in  STIR  images
s  more  robust  and  homogenous  than  a T2  with  fat  satura-
ion.  Certain  organs  have  a  physiological  STIR  hypersignal,  as
s  the  case  of  the  lymph  organs  (spleen,  thymus,  Waldeyer’s
ing)  and  the  kidneys.  In  case  of  nodular  inﬁltration  of  one  of
hese  organs,  the  lesions  are  visible  in  relative  hyposignal.
In  the  lymphadenopathies,  size  remains  a  discriminating
riterion,  as  is  the  case  with  other  standard  diagnostic  meth-
ds  of  imaging.  The  signal  of  the  liver  and  the  pancreas  is
elatively  low,  equal  that  of  muscle.  The  lesions  appear  in
ypersignal.
The  study  of  the  pulmonary  parenchyma  is  difﬁcult  with
RI  and  is  still  less  efﬁcient  than  with  CT-scan  in  the  detec-
ion  of  pulmonary  metastases.  The  difﬁculties  in  the  MRI
echnique  in  this  environment  is  due  to  the  low  signal/noise
atio  of  the  lung  because  of  its  low  concentration  in  pro-
ons,  a  very  short  T2  and  T2*  relaxation  times  due  to  the
iffusion  of  water  molecules  within  the  gradients  induced
y  the  air—tissue  interfaces  and  ﬁnally,  by  the  physiological
ovements  of  the  heart  and  respiration.  Nevertheless,  the
resence  of  pulmonary  inﬁltrates  induces  a  local  increase  in
he  signal  from  the  lung  (due  to  an  increase  in  the  proton
oncentration  and  a  reduction  in  the  magnetic  susceptibil-
ty  effects)  and  the  peri-  or  supra-centimetric  metastases
re  therefore,  easy  to  identify  in  hypersignal  on  the  STIR
equence.
The  STIR  sequence  is  interesting  in  the  detection  of
steomedullary  metastases  in  the  child.  Classically,  in  the
dult,  the  T1  sequence  is  most  useful  to  identify  metas-
ases  of  the  bone  marrow.  They  are  revealed  by  areas  of
edullary  tissue  replacement  in  labeled  hyposignal  within  a
at  medullary  environment  in  hypersignal.  In  the  child,  when
ones  of  hypercellular  red  marrow  persist  (T1  hyposignal),
he  STIR  sequence  is  of  use  in  detecting  tumour  inﬁltration.
ood  knowledge  of  the  physiological  modiﬁcations  in  the  sig-
al  from  the  bone  marrow  as  a  function  of  age  is  required  to
istinguish  the  areas  of  haematopoiesis  from  bone  lesions
15]. Nevertheless,  care  is  required  in  the  analysis  of  the
one  marrow  signal  in  STIR  sequences  since  although  the
ypersignal  of  the  red  marrow  is  theoretically  less  distinct
han  that  of  the  tumours,  there  is  a  lack  of  sequence  speci-
city,  in  particular,  in  post-  or  intra-therapeutic  situation.
n  the  child,  medullary  inﬁltration  may  be  focal  or  diffuse,
s  is  the  case  of  the  rhabdomyosarcomas,  neuroblastomas,
eukaemias,  medullary  hyperplasia  in  anaemia  or  treatments
y  haematopoietic  growth  factors.  One  disadvantage  of  the
equence  is  that  osteoblastic  metastases  may  be  overlooked
10].
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Figure 1. Coronal T1 (a) and STIR-weighted (b) whole body MR images obtained in a 4-year-old girl with a history of spontaneous fractures
during treatment of anaplastic lymphoma with leukemic manifestations. Reconstructions are a composite of successive coronal acquisition
stations. This MRI showed no abnormalities excluding a left lower metaphyseal STIR hypersignal, without signiﬁcant T1 hyposignal and
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The  acquisition  time  of  a  coronal  STIR  sequence  ranges
from  2  to  4 min  by  station,  depending  on  the  machine  and  the
parameters  used.  The  number  of  stations  varies  according  to
the  size  of  the  patient,  generally  from  4  to  6.  An  acquisition
only  with  STIR  sequences  may  be  considered  in  a  WB-MRI
protocol,  although  the  ideal  solution  to  analyse  the  whole
skeleton  (in  particular,  the  sternum,  ribs  and  scapula,  and
skull),  and  to  detect  lymphadenopathies,  would  then  be  to
acquire  the  sequence  in  2D.
T1
T1-weighted  (Spin  Echo)  sequences  are  used  to  search  for
bone  lesions.  They  have  the  merit  of  having  a  good  spa-
tial  resolution  and  a  short  time  of  acquisition.  In  2001,
Daldrup-Link  et  al.  exclusively  used  T1  with  good  reliabil-
ity,  except  for  short  bones  and  small  bones,  in  the  diagnosis
of  bone  metastasis  [16].  The  use  of  in-phase  and  out-of-
phase  gradient-echo  sequences  has  the  advantage  that  it
is  faster  but  less  sensitive  than  spin  echo.  Coronal  T1-
weighted  fast  spin  echo  sequences  are  particularly  of  use  in
the  assessment  of  fat  involutions  of  the  marrow  after  radio-
therapy  and  medullary  tissue  replacements  of  metastatic
origin  [17].  The  use  of  a  gadolinium  chelate  improves  the
sensitivity  and  diagnostic  speciﬁcity  in  the  identiﬁcation
of  lesions  since  pathological  tissue,  in  particular,  tumoral
tissue,  is  strongly  enhanced,  especially  if  the  fat  signal  is
eliminated  [6].  However,  a  systematic  contrast  enhanced
T1-weighted  sequence  in  the  whole  body  MRI  protocol
is  currently  not  recommended.  An  examination  protocol
w
i
t
cechanical stress?). Note signal artifacts of femoral neck due to
omprising  both  non-enhanced  coronal  T1  sequences  and
TIR  provide  greater  speciﬁcity  in  the  detection  of  marrow
nomalies  [18].
iffusion
iffusion  imaging  distinguishes  tissues  according  to  the
obility  of  water  molecules  at  the  microscopic  scale  that
irectly  depend  on  the  cellularity  of  the  tissue.  Cell  prolif-
ration  in  a  malignant  zone  reduces  the  diffusion,  visible  in
he  form  of  a  hypersignal  and  measurable  by  the  reduction
n  the  apparent  diffusion  coefﬁcient  (ADC).  As  a  result,  this
equence  provides  a  functional  approach  to  the  imaged  tis-
ues.  Diffusion  sequences  are  obtained  in  axial  sections.  The
arameters  recommended  for  this  sequence  are  contiguous
ections  5  to  8  mm  thick,  a·b  =  0  and  a  b  =  400  at  1000/mm2,
 2  NEX  for  the  b  =  0  and  5  to  6  NEX  for  the  b  max  and  coding
n  the  3  directions  so  as  to  be  able  to  calculate  the  ADC.
he  addition  of  successive  anatomic  stations  contiguously
cquired  in  the  axial  plane  provides  continuous  visualiza-
ion  in  the  axial  sections  of  the  whole  body  (autobinding  and
 coronal  reconstruction)  [19].  Diffusion  sequences  are  of
alue  in  the  screening  of  multiple  lesions,  in  particular,  bone
etastases  [20]. The  image  obtained  calls  to  mind  scinti-
raphic  images  when  the  greyscale  is  inverted  (Fig.  2).  It
s  now  possible  to  merge  the  images  obtained  in  diffusion
ith  STIR  sequences  to  obtain  both  anatomic  and  functional
nformation  and  approach  the  techniques  merging  diagnos-
ic  and  nuclear  imaging:  PET-CT,  scintigraphy-CT  [21].  For
orrect  analysis  of  the  diffusion  imaging,  it  is  important  to
544  S.  Canale  et  al.
Figure 2. A 17-year-old girl with lymphoma. Coronal whole body T1-W (a), STIR (b) and greyscale inverted DWI (c) show extensive
(bilateral) cervical, axillary, paraaortic, mesenteric, and pelvic lymph node involvement (continuous arrows). Note the relatively high signal
intensity of the bone marrow [e.g. in both femoral diaphyses (dashed arrows), indicating bone marrow hyperplasia (reconversion)]. Also
note insufﬁciently suppressed fat in the right ﬂank and buttock (arrowheads).
Images from: ‘‘Whole body diffusion-weighted imaging for staging malignant lymphoma in children’’. Kwee, T. C. et al. Pediatr Radiol 2010.
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e  familiar  with  the  normal  anatomic  structures  that  present
 physiological  hypersignal:  the  brain  and  the  marrow,  sali-
ary  glands,  Waldeyer’s  ring,  thymus,  spleen,  gallbladder,
drenal  glands,  prostate,  penis,  endometrium,  ovaries,  tes-
icles,  red  marrow  and  lymph  nodes.  Yellow  marrow  appears
ark  in  diffusion  imaging  because  the  suppression  of  fat  and
ed  marrow  in  children  is  hyperintense  due  to  the  restriction
n  diffusion  caused  by  the  hypercellularity.  The  interpre-
ation  of  marrow  anomalies  may  be  especially  difﬁcult  in
hildren.  In  a  recent  study,  normal  zones  of  limited  diffusion
n  the  marrow,  asymmetrically  distributed  and  independent
f  any  pathological  process,  were  observed  in  48%  of  all
ealthy  children  [22].  The  difference  between  benign  and
alignant  lymphadenopathies  based  on  apparent  diffusion
oefﬁcients  (ADC)  is  still  inadequate,  since  the  series  of  ADC
alues  of  normal  lymph  nodes  overlaps  those  of  metastatic
ymph  nodes61.  It  is  therefore  important  to  remember  that
iffusion  sequences  are  very  sensitive  but  lack  enough  speci-
city  to  be  able  to  reliably  conclude  on  the  basis  of  signal
nalysis,  in  particular,  in  the  above-mentioned  situations.
thers
ther  sequences,  such  as  magnetization  transfer  contrast
maging,  or  steady  state  free  precession  (SSFB),  have  been
ested  on  small  patient  samples  without  demonstrating  a
ajor  interest  or  superiority  in  the  ﬁeld  of  oncology  [23,24].
urrent clinical applications of WB-MRI in
aediatric oncology
he  most  important  clinical  application  of  WB-MRI  in  chil-
ren,  as  in  adults,  is  the  screening  of  the  metastatic  spread
(
s
s
if  cancer.  In  most  of  the  series  published,  MRI  discovers  more
esions  than  the  so-called  conventional  techniques,  and  in
articular,  more  than  the  examinations  in  nuclear  medicine
ith  which  they  are  in  direct  competition  [25—27].
ymphoma
ymphoma  is  the  third  most  common  malignancy  in  the
hild,  after  leukaemia  and  brain  tumours.  Accurate  stag-
ng  is  required  to  determine  the  most  appropriate  method
f  management,  and  CT  remains  the  mainstay  imaging
odality  for  this  purpose.  Recently,  PET-CT  has  come  into
se  for  staging  and  evaluation  of  treatment  response.
 great  many  studies  have  reported  the  non-inferiority
r  even  superiority  of  WB-MRI  over  conventional  imaging
nuclear  medicine  techniques  included)  in  the  staging  of
ymphomas  in  the  adult  and  child  as  regards  to  the  detection
f  supra-centimetric  lymphadenopathies  and  bone  marrow
nﬁltration  [4,28—30]  (Fig.  3).  Different  studies  carried  out
n  patients  with  lymphoma  have  shown  that  the  sensitiv-
ty  of  WB-MRI  ranges  from  92%  to  100%  in  the  detection  of
ymph  nodes  10  to  12  mm  in  diameter,  compared  to  a  sen-
itivity  of  67%  for  lymph  nodes  6  to  12  mm  in  diameter  and
1%  for  lymph  nodes  1  to  6  mm  in  diameter  [28,30].  How-
ver,  certain  studies  have  reported  that  WB-MRI  was  inferior
o  PET-CT,  in  particular,  in  the  detection  of  pulmonary  and
epatic  metastases  [31],  although  the  MRI  protocol  did  not
nclude  the  diffusion  sequence,  which  is,  today,  subject  to
riticism.
Diagnostic  hesitation  about  osteomedullary  involvement
moderate  hyperﬁxation  in  FDG-PET  and  negative  medullary
amples)  is  a  good  indication  for  WB-MRI.  Nevertheless,  out-
ide  of  stages  1  and  2,  in  which  the  discovery  of  medullary
nvolvement  that  has  not  been  diagnosed  by  another  method
Whole  body  MRI  in  paediatric  oncology  545
Figure 3. Lymphoma in a 12-year-old boy. Coronal STIR MR images (a—c) show lymphadenopathy in the neck, axillae, mediastinum, lungs,
and left inguinal region (arrowheads). Lymphomatous inﬁltrates are seen in the marrow of the pelvic bones and the right knee (arrows).
Coronal PET image (d) clearly depicts all these lesions (arrows).
Images from: ‘‘Whole body MR imaging in children: principles, technique, current applications, and future directions’’. Chavhan, G. B. and
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modiﬁes  the  treatment,  the  increase  in  the  number  of
lesions  detected  does  not  modify  the  care.  Although  MRI  may
show  the  regression  of  bone  marrow  signal  anomalies  under
treatment,  it  is  not  sufﬁciently  speciﬁc  and  does  not  seem
more  reliable  than  the  conventional  techniques  in  the  diag-
nosis  of  residual  disease.  In  this  indication,  positron  emission
tomography  (FDG-PET)  has  today,  as  opposed  to  MRI,  an
acknowledged  beneﬁt  [32,33].
Solid tumours
In  the  adult,  certain  studies  demonstrate  the  superiority  of
WB-MRI  over  other  imaging  procedures  in  the  detection  of
hepatic,  skeletal  and  central  nervous  system  metastases  in
solid  tumours  [34].  In  particular,  in  the  detection  of  bone
metastases,  the  sensitivity  of  WB-MRI  is  similar  or  supe-
rior  that  of  bone  scintigraphy  with  technetium  99  m.  Most
authors  report  a  sensitivity  of  over  97%  for  WB-MRI  in  this
indication  [11].  In  the  child,  series  on  small  cell  tumours
are  more  limited  and  heterogeneous  [35]. In  a  ﬁrst  study,
where  the  authors  only  used  a  T1-weighted  sequence,  the
sensitivity  of  the  PET-CT  was  higher  (90%)  than  the  sensi-
tivity  of  WB-MRI  (82%)  in  the  assessment  of  the  spread  of
different  malignant  tumours  in  the  child  [16]. The  results
of  subsequent  studies,  in  which  the  STIR  sequence  was  used
in  addition  to  the  T1-weighted  sequence,  have  shown  that
d
p
S
wadiological Society of North America.
he  sensitivity  of  WB-MRI  becomes  similar  to  that  of  the  PET-
T  [36,37].  In  2010,  Goo  et  al.  published  an  article  on  the
alue  of  WB-MRI  in  initial  monitoring  (local  and  metastatic)
nd  the  monitoring  of  neuroblastomas  (Fig.  4)  [17].  He
mphasized  the  promising  aspect  of  the  technique  as  well
s  the  need  to  assess  it  on  larger  prospective  cohorts  with
he  systematic  use  of  diffusion  sequences.  He  also  noted
he  limits  of  the  technique:  the  assessment  of  lymph  node
nvolvement,  the  differentiation  between  viable  and  resid-
al  non-viable  tumour,  and  the  detection  of  calciﬁed  lesions.
inally,  the  author  emphasized  the  potential  complementar-
ty  between  WB-MRI  and  metabolic  methods  of  imaging  to
mprove  the  diagnostic  speciﬁcity  in  these  difﬁcult  situa-
ions.
esults of the ACRIN study
he  American  College  of  Radiology  Imaging  Network  (ACRIN)
rotocol  [31]  is  a  multicentric  prospective  study  (20  centers)
arried  out  in  North  America  between  November  2004  and
une  2007.  The  main  goal  of  this  study  was  to  establish  the
on-inferiority  of  WB-MRI  over  conventional  imaging  in  the
etection  of  metastases  in  the  initial  assessment  of  current
aediatric  tumours.  WB-MRI  was  carried  out  with  coronal
TIR  sequences  and  the  conventional  imaging  procedures
ere  those  currently  used  in  everyday  practice  for  initial
546  S.  Canale  et  al.
Figure 4. Seven year-old girl with stage 4 neuroblastoma. a: coronal whole body STIR MR image shows heterogeneously hyperintense bone
marrow the lumbar spines, the pelvis, both femora, and the left tibia (arrowhead). The primary tumour (arrows) is also seen in the left
lower abdomen and the whole body diffusion-weighted image reveals extensive bone marrow metastases (arrows), conspicuously because
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mages from: ‘‘Whole body MRI of neuroblastoma’’. Goo, H. W.  Eur
ssessments:  CT-scan  of  the  thorax,  scintigraphies  (bone,
IBG,  gallium)  and  PET-FDG.  The  tumours  studied  were
ymphomas,  neuroblastomas  and  sarcomas  of  soft  tissue.
ixty-six  patients  under  the  age  of  21  were  analyzed  (mean
ge:  10  years).  The  study  was  not  able  to  establish  that  the
iagnostic  precision  by  WB-MRI  was  not  inferior  to  that  of
onventional  imaging  in  the  detection  of  remote  metastases
n  the  patient  selected.  However,  it  shows  that  the  detec-
ion  of  metastases  by  WB-MRI  is  more  precise  in  paediatric
atients  with  solid  tumours  than  in  those  with  lymphomas
mean  area  under  ROC  curve  0.92  vs  0.72,  respectively,
 =  0.006).  It  also  shows  that  WB-MRI  helps,  on  the  aver-
ge,  detect  more  skeletal  lesions  than  conventional  imaging
P  =  0.03)  but  does  not  improve  the  detection  of  pulmonary
etastases  (mean  sensitivity,  0.53  vs  0.83,  respectively,
 =  0.001).  These  results  support  past  studies  that  show  that
TIR  sequences  were  better  than  scintigraphy  in  the  detec-
ion  of  bone  metastases.  Whole  body  MRI  is  less  efﬁcient  in
he  detection  of  extra-skeletal  disease.  Most  of  the  lesions
issed  in  this  study  were  under  1  cm  in  diameter  and  all
ere  located  in  the  lungs  or  liver.  The  under-diagnosis  of
ung  disease  with  WB-MRI  is  not  surprising  as  it  has  been
emonstrated  by  other  authors  [7,38].  The  advantage  of  this
tudy  is  that  all  of  the  participants  used  a  single  STIR  tech-
ique.  One  of  the  weaknesses  is  that  the  diffusion  was  not
ssessed  as  this  seems  promising  in  improving  the  detection
f  lesions  [39,40].
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sdiol 2010. Reproduced by kind permission of Elsevier.
re-clinical screening of children with a
ancer predisposition syndrome
B-MRI  may  be  of  use  in  the  pre-clinical  screening
f  cancers  in  patients  presenting  a  genetic  predis-
osition  to  cancer  (retinoblastoma,  Von  Hippel—Lindau
isease,  familial  adenmatous  polyposis,  neuroﬁbromatoses,
eckwith—Wiedmann  disease,  Li—Fraumeni  syndrome,  etc.)
41]. The  Li—Fraumeni  syndrome  is  a rare  autosomal  dom-
nant  hereditary  disease,  caused  by  a  germ-like  mutation
f  the  tumour  suppressor  gene  p53. Children  with  this
yndrome  are  predisposed  to  develop  certain  malignant
umours,  including  breast  cancer,  brain  tumours  (carcinoma
f  the  choroid  plexus,  etc.),  acute  leukaemia,  soft  tissue
arcoma,  and  corticosurrenalomas.  A  pilot  study  carried  out
t  Dana  Farber  Institute  has  shown  that  the  use  of  the  PET-
can  may  enable  the  detection  of  asymptomatic  tumours  in
hese  patients  [42].  However,  these  patients  are  particularly
ensitive  to  ionizing  radiation.  A  North-American  study  on
9  persons  from  8  Li—Fraumeni  families,  reported  the  inci-
ence  and  mortality  by  cancer  in  these  subjects  whether
onitored  (n  =  16)  or  not  (n  =  38)  by  imaging,  including  a
hole  body  MRI.  After  38  months,  6  monitored  individuals
eveloped  a  total  of  9  cancers  (brain  tumours)  and  were
live,  whereas  22/33  non-monitored  individuals  died  [43].
his  study  tends  to  demonstrate  the  usefulness  of  tumour
creening  in  this  population.  Our  institution  is  the  main
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investigator  in  a  national  multicentric  randomized  study
that  began  at  the  end  of  2011  to  assess  the  value  of  whole
body  MRI  with  diffusion  sequences  in  the  pre-clinical  detec-
tion  of  cancer  in  carriers  of  constitutional  mutation  P53
(Lifescreen  study,  subjects  5  to  71-years-old),  the  clinical
criterion  of  judgement  being  the  incidence  of  cancer  after
3  years.
Future prospects for the development of
WB-MRI in paediatric oncology
Diffusion imaging
The  inclusion  of  diffusion  data  improves  the  speciﬁcity  of
WB-MRI  by  providing  information  about  tumoral  cellularity
and  necrosis  [44].  In  the  past,  diffusion  imaging  with  free
breathing  was  considered  impossible.  For  this  reason,  the
sequences  were  obtained  with  apnea  or  gating,  thereby,
deteriorating  the  signal/noise  ratio  due  to  the  great  sec-
tion  thickness  or  prolongation  of  the  acquisition  time.  In
2004,  Takahara  et  al.  [45]  demonstrated  that  the  breathing
movement  occurring  during  the  application  of  the  diffusion
gradient  is  a  coherent  intravoxel  movement  that  does  not
affect  the  diffusion  weighting,  even  if  it  provokes  a  cer-
tain  blur  in  the  images.  He  developed  a  new  free  breathing
diffusion  imaging  technique  with  3D  maximum  intensity  pro-
jection  (MIP)  reconstructions,  allowing  for  the  acquisition
of  thin  sections  within  a  reasonable  time  frame.  The  tech-
nique  is  called  diffusion-weighted  imaging  background  body
signal  suppression  (DWIBBS).  In  addition  to  free  breathing,
s
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Figure 5. Whole body DW imaging versus FDG-PET for monitoring thera
grayscale DW images obtained before (a) and 5 months after treatment 
signal intensity is considered to be within normal limits. Bone marrow
hyperintense signal is not seen at sites of nodal disease, consistent with
hypointensity (both pre- and post-therapy DW images are normalized to 
before (c) and after therapy (d) show complete response to therapy. FD
not visible on diffusion.
Images from: ‘‘Whole body diffusion-weighted MR imaging in cancer: cu
Collins, D. J. Radiology 2011. Reproduced by kind permission of the Radi547
his  technique  is  characterised  by  the  high  diffusion  weight-
ng  (b  =  1000—1500  s/mm2)  and  fat  suppression  obtained
y  inversion  recovery  as  in  the  STIR  sequence  [46].  With
he  suppression  of  the  background  noise  (normal  anatomic
tructures),  only  the  structures  and  lesions  restricting  the
iffusion  are  represented.  The  resulting  images  are  in  gen-
ral  displayed  in  an  inverted  greyscale  and  resemble  PET
mages.  For  a  better  analysis,  it  is  often  necessary  to  refer
o  the  underlying  anatomy.  Image  fusion  software  now  can
e  used  to  calibrate  the  diffusion  on  a  STIR  or  T1  sequence.
n  2009,  Kwee  et  al.  described  that  the  addition  of  weighted
iffusion  sequences  in  the  whole  body  MRI  protocol  provided
 more  exact  staging  of  lymphomas  by  correctly  readjust-
ng  the  stage  upwards  in  4  of  the  28  patients  analyzed
47].
Lesions  in  diffusion  hypersignal  (black  on  the  image  in
nverted  greyscale),  with  a  high  value  of  b  do  not  always
ndicate  the  presence  of  limited  diffusion.  This  is  why  the
oncomitant  quantitative  analysis  of  ADC  measurements
n  colour  mapping  is  required  [39]. This  technique  does
ot  require  the  administration  of  contrast  agent  and  does
ot  use  ionising  radiation.  It  is  especially  advantageous
n  repeated  follow-ups,  in  particular,  in  monitoring  under
hemotherapy  [48].  ADC  measurement  within  a  large  organ
s  relatively  uniform  and  fairly  precise  with  free  breathing
lthough  it  seems  to  be  less  reliable  for  small  focal  lesions
ue  to  the  contamination  of  the  signal  by  the  adjacent  tis-
ue  [49]. The  optimisation  of  ADC  measurements  is  the  main
irection  of  future  on  the  diffusion  sequence.  The  ﬁnal  goal
s  to  obtain  a reliable  functional  biomarker,  like  SUV  mea-
urements  in  PET-CT  [19].
py response in a 23-year-old man  with Hodgkin lymphoma. Inverted
(b) show supradiaphragmatic distribution of nodal disease. Splenic
 signal is hyperintense but normal for the age. After therapy, a
 the therapy response. Note interval development of bone marrow
right kidney signal intensity). Whole body FDG-PET-scans obtained
G-PET-scan shows splenic deposit before therapy (arrow), which is
rrent status and research directions’’. Padhani, A. R., Koh, D.-M.,
ological Society of North America.
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Figure 6. FDG-PET (a) and MR (b) images acquired separately and fused PET/MR image (c) obtained by using software show an Ewing
sarcoma of the pelvis (arrows) in an 11-year-old boy.
Courtesy of Ruth Lim, MD, Department of Pediatric Radiology, Massachusetts General Hospital, Harvard University, Boston, Mass, and with
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urrent applications, and future directions’’. Chavhan, G.B. and Ba
A  great  many  studies  compare  diffusion  imaging  and  PET-
DG  in  adults  and  show  similar  results  with  both  procedures
Fig.  5).  A  study  has  still  not  been  carried  out  to  compare
hole  body  diffusion  MRI  and  PET-FDG  in  children.
 Tesla MRI
he  WB-MRI  technique  on  3  Tesla  (3  T)  machines  is  currently
ifﬁcult  to  use  on  a  routine  basis  since  it  still  requires
djustments  to  reduce  the  signal  non-homogeneities  and  the
usceptibility  to  artifacts.  A  great  many  related  artifacts  are
n  fact  increased  with  a  high  ﬁeld.  This  is  the  case  of  the
on-homogeneity  of  b0  and  b1,  motion  and  magnetic  suscep-
ibility  artefacts  and  difﬁculties  in  the  suppression  of  the  fat
ignal.  Several  teams  have  worked  on  ways  to  improve  3  T
iffusion  sequences.  This  work,  in  particular,  involves  the
se  of  dual-source  radiofrequency  transmission  technology
o  reduce  ﬁeld  non-homogeneities  [50],  and  the  suppression
f  fat  by  slice  selection  gradient  reversal  (SSGR),  which  is
ore  robust  at  3  T  [51].  The  prime  interest  in  the  use  of
 T  promoted  by  the  manufacturers  is  the  theoretical  pos-
ibility  of  reducing  the  overall  acquisition  time  for  whole
ody  imaging  and  thereby,  improving  the  paediatric  patient
omfort.
ET/MRI
he  simultaneous  acquisition  of  morphological  and  func-
ional  data  by  hybrid  PET-MRI  technology  is  a  new,  rapidly
rowing,  diagnostic  and  lesion  characterization  method
52—54].  The  joint  study  of  the  metabolism  of  glucose  and
he  cellularity  within  tumour  tissue  enables  more  sophis-
icated  characterization.  For  example,  PET  improves  the
etection  of  abnormal  metabolic  activity  in  lymph  nodes
hat,  in  the  MRI,  would  not  have  been  noticed  due  to  their
ormal  size  and  their  hypersignal  in  physiological  diffusion.
iffusion  imaging  may,  in  turn,  effectively  complement  PET
n  the  evaluation  of  urinary  tract  disease  that  naturally
S
b
m
drom: ‘‘Whole body MR imaging in children: principles, technique,
P.S. Radiographics 2011.
xcretes  the  radionucleotide.  The  ﬁrst  clinical  research  car-
ied  out  in  this  ﬁeld  was  published  in  2008  [55,56].  However,
his  technique  is  complex  and  involves  new  problems  and
hallenges,  including  the  reduction  of  artefacts  and  the  opti-
isation  of  the  examination  procedure  beyond  the  simple
erger  of  2  sets  of  image  data.  Certain  teams  are  working
n  the  optimisation  of  this  new  technology  in  order  to  pro-
ose  an  efﬁcient  clinical  tool  that  can  be  used  on  a  routine
asis  [54,57]  (Fig.  6).
onclusion
hole  body  MRI  is  a  technique  that  can  now  be  used  on
 routine  basis  and  is  promising  in  paediatric  oncology.
ts  role  with  respect  to  nuclear  medicine  examination  still
as  not  been  clearly  determined,  although  the  number  of
tudies  demonstrating  the  similar  efﬁcacy  of  these  two
ethods  is  constantly  increasing.  This  exhaustive  review  of
he  literature  concludes  that  WB-MRI  is  superior  to  scintig-
aphy  and  PET-CT  in  the  detection  of  bone,  brain  and  liver
esions  but  remains  inferior  for  the  detection  of  small  lym-
hadenopathies  and  pulmonary  lesions.  The  major  value  of
his  technique  in  paediatrics  is  that  it  is  radiation  free.  The
ain  limitations  are  the  length  of  the  examination,  the  lack
f  spatial  resolution  in  the  detection  of  small  lesions  and  the
ack  of  speciﬁcity  for  the  evolution  under  treatment,  in  par-
icular,  for  bone  marrow  lesions.  The  current  optimisation  of
iffusion  sequences  and  PET-MRI  are  innovative  techniques
hat  may  eventually  improve  the  last  shortcoming.  In  conclu-
ion,  a  standardised  whole  body  paediatric  protocol  within
 context  of  metastatic  screening  for  diagnostic  purposes
ay  be  suggested:  coronal  STIR  sequences  and  axial  diffu-
ion  on  the  whole  body,  more  or  less  completed  with  sagittal
TIR  sequences  on  the  spine.  This  protocol  is  a  compromise
etween  the  detection  sensitivity  of  skeletal  and  visceral
etastases  and  a  reasonable  acquisition  time  for  the  pae-
iatric  population.  It  does  not  pretend  to  provide  a  ﬁne
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analysis  of  the  primary  tumour  at  the  same  time.  Targeted
and  homogenous  studies  are  still  required  to  specify  the  role
of  WB-MRI  in  each  type  of  paediatric  tumour,  at  the  time  of
the  diagnosis  or  during  the  follow-up.  In  this  way,  the  techni-
cal  parameters  may  be  optimised  and  standardised  for  each
indication.
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